IMNM
Price:
$18.74
Market Cap:
$1.79B
Immunome, Inc. functions as a biopharmaceutical company dedicated to the discovery and advancement of antibody-based therapies for both cancer and infectious illnesses. A pivotal project in its oncology portfolio is IMM-ONC-01, which is engineered to target the IL-38 immune checkpoint – a protein originating from tumors that enables cancer cells to bypass the body's immune surveillance. Additionally, the company is developing IMM-BCP-01, an experimental antibody cocktail designed for the management of SARS-CoV-2 infections and COVID-19. This enterprise was founded in 2006 and its principal operations are based in Exton, Pennsylvania.
Industry
Biotechnology
IPO Date
2020-10-02
Stock Exchange
NASDAQ
Ticker
IMNM
According to Immunome, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Immunome, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), IMNM's Dividend Yield was at its highest in in the March 2019 quarter at 0%. The Dividend Yield was at its lowest in in the March 2019 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Immunome, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0% | 0% |
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
The current Dividend Yield of Immunome, Inc. (IMNM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Immunome, Inc.’s Dividend Yield is less than Pharvaris N.V. (0%), less than Spyre Therapeutics, Inc. (0%), less than Intellia Therapeutics, Inc. (0%), less than Upstream Bio, Inc. (0%), less than Biohaven Ltd. (0%), less than Maze Therapeutics, Inc. (0%), less than Vera Therapeutics, Inc. (0%), less than AbCellera Biologics Inc. (0%), less than Celldex Therapeutics, Inc. (0%), less than Zenas BioPharma, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $2.29B | |
| 0% | $5.34B | |
| 0% | $1.76B | |
| 0% | $340.12M | |
| 0% | $1.44B | |
| 0% | $1.42B | |
| 0% | $2.52B | |
| 0% | $1.69B | |
| 0% | $2.16B | |
| 0% | $883.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunome, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Immunome, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Immunome, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Immunome, Inc. (IMNM)?
What is the highest Dividend Yield for Immunome, Inc. (IMNM)?
What is the 3-year average Dividend Yield for Immunome, Inc. (IMNM)?
What is the 5-year average Dividend Yield for Immunome, Inc. (IMNM)?
How does the current Dividend Yield for Immunome, Inc. (IMNM) compare to its historical average?